← Patent-cliff monitor small molecule VTAMA TAPINAROF
Loss of exclusivity December 2039 latest FDA-listed patent expiry
Company Organon → View the full company profile on CliffBio Drug detail Brand name VTAMA Active ingredient TAPINAROF Strength 1% Dosage form CREAM Route TOPICAL Modality Small molecule FDA approval May 2022 Marketing status RX
Listed patents Patent Expires Type 12569453 December 2039 use U-4048 11938099 November 2039 use U-4048 11590088 November 2039 use U-2625 11497718 November 2039 use U-4048 10647649 November 2038 substance 11597692 November 2038 substance, product 10195160 May 2036 product 10426743 May 2036 use U-2625 11617724 May 2036 product 11458108 May 2036 product 11622945 May 2036 product 11612573 May 2036 use U-2625
Regulatory exclusivity Code Expires I-956 December 2027 NCE May 2027
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.